Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM)

CUSIP: 05464T104

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
48,932,355
Total 13F shares
38,597,370
Share change
+300,290
Total reported value
$3,071,777,083
Put/Call ratio
55%
Price per share
$79.59
Number of holders
242
Value change
+$30,855,225
Number of buys
104
Number of sells
110

Quarterly Holders Quick Answers

What is CUSIP 05464T104?
CUSIP 05464T104 identifies AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q4 2023

As of 31 Dec 2023, Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) was held by 242 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 38,597,370 shares. The largest 10 holders included RTW INVESTMENTS, LP, VANGUARD GROUP INC, BlackRock Inc., Fairmount Funds Management LLC, BVF INC/IL, CITADEL ADVISORS LLC, PERCEPTIVE ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Deep Track Capital, LP, and STATE STREET CORP. This page lists 243 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.